KiLeeMilliganMD

Executive Director, Pediatric Center of Excellence, Global Drug Development

Dr. Milligan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 2013 - 2016
SSM Health/Saint Louis University School of MedicineResidency, Pediatrics, 2009 - 2013
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Transitional Year, 2001 - 2002
UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 2001

PubMed

6 citations
Ataxia telangiectasia associated with nodular regenerative hyperplasia.
Ki Lee Milligan, Karen Schirm, Stephanie A. Leonard, Ashleigh A. Hussey, Anahita Agharahimi
Journal of Clinical Immunology. 2016-09-26
19 citations
Complete Myeloperoxidase Deficiency: Beware the "False-Positive" Dihydrorhodamine Oxidation.
Ki Lee Milligan, Daphne Mann, Amy P. Rump, Victoria L. Anderson, Amy P. Hsu
The Journal of Pediatrics. 2016-09-01
3 citations
Ataxia telangiectasia presenting as hyper IgM syndrome without neurologic signs.
Ashmi Doshi, Julie Ryu, Courtney D. Thornburg, Daniel Hershey, Rebecca Cherry
Annals of Allergy, Asthma & Immunology. 2016-09-01